Actinium-225, a weapon for the fight against cancer
Speaker
-
Sven Van den Berghe
Sven Van den Berghe is a master of physics graduate of the university of Ghent with a PhD in materials science from the university of Limoges in France, in collaboration with the Institute for Transuranic Elements in Germany and the Belgian nuclear research centre SCK-CEN. He has held the position of head of the Microstructural and Nondestructive Analysis laboratory at the SCK CEN Hotlab for 15 years before becoming the BR2 reactor stakeholder manager. In 2018, he was appointed as the director of the Nuclear Materials Science institute of the SCK CEN, which hosts the BR2 reactor and the hot laboratories.
In 2022 Sven has been appointed CEO For PanTera, a spin-off between SCK CEN and IBA to develop, design and build a production facility for Ac-225 in the battle against cancer. The motivation to take up this position in leading a new company is the idea that the products PanTera will create will signify new hope for cancer patients around the world.